Pricing Log in Create free account

Bio Green Med Solution, Inc. (BGMS) vs Orgenesis Inc. (ORGS)

Bio Green Med Solution, Inc. and Orgenesis Inc. are both Biotechnology companies. Bio Green Med Solution, Inc. and Orgenesis Inc. are of similar size ($5.7M and $5.5M). Bio Green Med Solution, Inc. grew revenue faster over the last twelve months: 2,414.9% against 95.3%. Bio Green Med Solution, Inc. has the higher net margin (−715.5% vs −4,653.6%) and the lower return on invested capital (−67.3% vs 0.00%). Across the 17 metrics below, Bio Green Med Solution, Inc. leads on 12 and Orgenesis Inc. on 5.

Valuation

Metric BGMS ORGS Biotechnology median
P/E n/m n/m 8.50
P/S 2.74 0.24 9.71
P/B 0.71 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.70 15.71 9.21
Earnings yield (400.00%) (19,183.33%) (33.15%)
Free cash flow yield (19.67%) (6,862.91%) (25.50%)

Profitability

Metric BGMS ORGS Biotechnology median
Gross margin 19.34% (86.28%) 65.16%
Operating margin (194.95%) (3,842.32%) 0.00%
Net margin (715.48%) (4,653.62%) 0.00%
Free cash flow margin (59.00%) (1,675.27%) 0.00%
Return on equity (246.85%) 164.62% (56.36%)
Return on assets (217.30%) (605.73%) (48.04%)
Return on invested capital (67.28%) 0.00% 0.00%

Growth

Metric BGMS ORGS Biotechnology median
Revenue growth (TTM) 2,414.86% 95.28% 6.02%
EPS growth (last fiscal year) 98.71% 40.10% 30.26%
Revenue growth, 5-year CAGR (17.41%) (23.30%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGMS ORGS Biotechnology median
Debt to equity 0.00 (0.44) 0.00
Current ratio 8.63 0.03 4.72
Net debt to EBITDA 0.42 (0.42) 0.96

Dividend

Metric BGMS ORGS Biotechnology median
Dividend yield 0.00% — 0.09%
Payout ratio — — —

Size

Metric BGMS ORGS Biotechnology median
Market cap 5.51m 5.68m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack